CHICAGO—The consequences of diminishing federal support for cancer research can be measured in the abstracts presented at the 50th annual meeting of the American Society of Clinical Oncology that concluded earlier this week.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
